EIF5B and prostate carcinoma: In this study, we demonstrated that Wig1 overexpression could inhibit PD-L1 expression and proliferation of prostate cancer cells, which is consistent with the results of Cortez et al. Furthermore, previous studies have shown that Wig1 can bind to eIF5B at the initial stage of translation, resulting in translation inhibition [13].